title: Financial incentives and drug spending in managed care.
abstract: Pharmaceutical costs have been rising dramatically since 1995, growing 16.6% in 1998 alone. This rate of increase is more than four times that of all health care spending. Employers, managed care organizations and consumers are looking anew for ways to stem these rising costs, without denying patients effective care. Therefore, this Issue Brief is especially timely because it investigates how patient copayments and financial incentives for physicians affect drug spending in managed care.
authors.affiliation: University of Pennsylvania, USA.
authors.forename: A L
authors.initials: AL
authors.lastname: Hillman
authors.forename: M V
authors.initials: MV
authors.lastname: Pauly
authors.forename: J J
authors.initials: JJ
authors.lastname: Escarce
authors.forename: K
authors.initials: K
authors.lastname: Ripley
authors.forename: M
authors.initials: M
authors.lastname: Gaynor
authors.forename: J
authors.initials: J
authors.lastname: Clouse
authors.forename: R
authors.initials: R
authors.lastname: Ross
mesh_terms: D017047:Cost Sharing / Q000191:economics*; D016527:Drug Costs; D006291:Health Policy; D006801:Humans; D007193:Independent Practice Associations; D008329:Managed Care Programs / Q000191:economics; D009819:Office Visits / Q000191:economics; D010816:Physician Incentive Plans / Q000191:economics; D014481:United States